MedTrace Logo

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"

NCT01151202 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 236

Last updated 2010-10-05

No results posted yet for this study

Summary

The purpose of this study is to assess therapeutic confirmation of AG NPP709 syrup to evaluate the safety and efficacy in patients with acute upper respiratory tract infection and chronic inflammatory bronchitis.

Conditions

  • Acute Upper Respiratory Tract Infections
  • Bronchitis

Interventions

DRUG

AG NPP709syrup

Sponsors & Collaborators

  • Kyunghee University Medical Center

    collaborator OTHER

  • Inha University Hospital

    collaborator OTHER

  • Ewha Womans University

    collaborator OTHER

  • Hanyang University

    collaborator OTHER

  • Konkuk University Medical Center

    collaborator OTHER

  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Young-ho Na, PhD, MD · Kyung Hee University Medical Center, Department of Pediatrics,

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
24 Months
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-05-31
Completion
2010-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01151202 on ClinicalTrials.gov